ArticleBritish journal of cancer2025

Genomic landscape of estrogen receptor-positive HER2-negative advanced breast cancer with acquired resistance to aromatase inhibitors: Identification of an ESR1 alteration-related gene signature.

Solenn Barraud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.